Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minimally ...
Spruce Biosciences offers a high-risk, high-reward opportunity as it advances TA-ERT, potentially the first disease-modifying therapy for MPS IIIB, toward FDA approval. TA-ERT demonstrated durable ...
Supported by the National Institute of Health T32GM145408 to C.R-C. Supported by NINDS R61 NS122096, NCI R37CA27685, the Mayo Clinic Center for Individualized Medicine and CCaTS award UL1TR002377, ...
Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results